$2.44 EPS Expected for Laboratory Corp. of America Holdings (LH)

July 18, 2017 - By Adrian Mccoy

 $2.44 EPS Expected for Laboratory Corp. of America Holdings (LH)
Investors sentiment increased to 1.02 in Q4 2016. Its up 0.01, from 1.01 in 2016Q3. It improved, as 48 investors sold Laboratory Corp. of America Holdings shares while 220 reduced holdings. 76 funds opened positions while 197 raised stakes. 92.34 million shares or 0.26% less from 92.58 million shares in 2016Q3 were reported.
New York-based Cipher Capital L P has invested 0.26% in Laboratory Corp. of America Holdings (NYSE:LH). Ahl Partners Ltd Liability Partnership reported 14,839 shares stake. Gemmer Asset Mngmt Ltd Company reported 21 shares. Security Tru Communications stated it has 0.07% in Laboratory Corp. of America Holdings (NYSE:LH). Cornerstone owns 204 shares. 17 were accumulated by Rocky Mountain Advisers Ltd Liability Com. 108,963 are held by Hallmark Mgmt. Oppenheimer Company Inc owns 2,396 shares. 1.67 million were accumulated by Iridian Asset Management Limited Liability Ct. 10,340 were accumulated by Advantus Capital Mgmt Inc. Zurcher Kantonalbank (Zurich Cantonalbank) invested in 38,869 shares or 0.05% of the stock. Lsv Asset has invested 0.01% in Laboratory Corp. of America Holdings (NYSE:LH). Moreover, Norinchukin National Bank & Trust The has 0.02% invested in Laboratory Corp. of America Holdings (NYSE:LH) for 6,248 shares. 26,000 are owned by Employees Retirement Sys Of Texas. Millennium Mgmt Ltd Llc stated it has 0.11% of its portfolio in Laboratory Corp. of America Holdings (NYSE:LH).

Since February 23, 2017, it had 0 insider buys, and 5 insider sales for $2.01 million activity. On Thursday, February 23 ANDERSON KERRII B sold $278,880 worth of Laboratory Corp. of America Holdings (NYSE:LH) or 1,992 shares. 3,613 shares valued at $505,259 were sold by BERBERIAN LANCE on Monday, May 22. On Tuesday, May 9 the insider BELINGARD JEAN-LUC sold $141,052. $327,690 worth of stock was sold by EISENBERG GLENN A on Thursday, March 9. On Friday, February 24 MITTELSTAEDT ROBERT E JR sold $756,258 worth of Laboratory Corp. of America Holdings (NYSE:LH) or 5,300 shares.

Analysts await Laboratory Corp. of America Holdings (NYSE:LH) to report earnings on July, 26. They expect $2.44 EPS, up 5.63 % or $0.13 from last year’s $2.31 per share. LH’s profit will be $251.34M for 15.75 P/E if the $2.44 EPS becomes a reality. After $2.22 actual EPS reported by Laboratory Corp. of America Holdings for the previous quarter, Wall Street now forecasts 9.91 % EPS growth. The stock increased 0.23% or $0.35 during the last trading session, reaching $153.68. About 291,570 shares traded. Laboratory Corp. of America Holdings (NYSE:LH) has risen 10.51% since July 18, 2016 and is uptrending. It has underperformed by 6.19% the S&P500.

Laboratory Corp. of America Holdings (NYSE:LH) Ratings Coverage

Among 13 analysts covering Laboratory Corp (NYSE:LH), 4 have Buy rating, 0 Sell and 9 Hold. Therefore 31% are positive. Laboratory Corp had 26 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Canaccord Genuity with “Buy” on Tuesday, June 27. Credit Suisse maintained Laboratory Corp. of America Holdings (NYSE:LH) on Thursday, May 25 with “Buy” rating. Robert W. Baird downgraded it to “Neutral” rating and $138 target in Monday, February 6 report. RBC Capital Markets maintained the stock with “Sector Perform” rating in Friday, February 19 report. The stock of Laboratory Corp. of America Holdings (NYSE:LH) earned “Buy” rating by Canaccord Genuity on Tuesday, April 26. The company was downgraded on Monday, August 17 by Zacks. On Tuesday, December 8 the stock rating was downgraded by Goldman Sachs to “Neutral”. Credit Suisse downgraded Laboratory Corp. of America Holdings (NYSE:LH) rating on Wednesday, July 12. Credit Suisse has “Hold” rating and $14600 target. The rating was maintained by Jefferies with “Hold” on Friday, June 9. On Tuesday, June 27 the stock rating was downgraded by KeyBanc Capital Markets to “Sector Weight”.

Laboratory Corporation of America Holdings is a life sciences firm that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The company has market cap of $15.83 billion. The Firm operates as a healthcare diagnostics company. It has a 21.17 P/E ratio. The Firm operates through two divisions: LabCorp Diagnostics and Covance Drug Development (CDD).

More news for Laboratory Corp. of America Holdings (NYSE:LH) were recently published by: Nasdaq.com, which released: “Commit To Buy Laboratory Corporation of America Holdings At $140, Earn 4.3 …” on June 27, 2017. Gurufocus.com‘s article titled: “Watch Point Trust Co Buys Vanguard Total Stock Market, iShares Core US …” and published on July 17, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.